Epstein Secrets

sts also exist for mental health programs and trauma therapy programs for female inmates. See Office of the Inspector General, U.S. Dep't of Just., Review of the Federal Bureau of Prisons' Use of Restrictive Housing for Inmates with Mental Illness 51 (2017); Office of the Inspector General, U.S. Dep't of Just., Review of the Federal Bureau of Prisons' Management of Its Female Inmate P

stice, Bureau of Prisons, Drug Abuse Treatment Program, 81 Fed. Reg. 24484, 24488 (Apr. 26, 2016) ("over 5,000 inmates waiting to enter treatment"); Colson Task Force, at 36 Cat the end of FY 2014, more than 12,300 people systemwide were awaiting drug abuse treatment'). 20 EFTA00100213 EXHIBIT B EFTA00100214

sts also exist for mental health programs and trauma therapy programs for female inmates. See Office of the Inspector General, U.S. Dep't of Just., Review of the Federal Bureau of Prisons' Use of Restrictive Housing for Inmates with Mental Illness 51 (2017); Office of the Inspector General, U.S. Dep't of Just., Review of the Federal Bureau of Prisons' Management of Its Female Inmate P

stice, Bureau of Prisons, Drug Abuse Treatment Program, 81 Fed. Reg. 24484, 24488 (Apr. 26, 2016) ("over 5,000 inmates waiting to enter treatment"); Colson Task Force, at 36 Cat the end of FY 2014, more than 12,300 people systemwide were awaiting drug abuse treatment'). 20 EFTA00064950 EXHIBIT B EFTA00064951

sts also exist for mental health programs and trauma therapy programs for female inmates. See Office of the Inspector General, U.S. Dep't of Just., Review of the Federal Bureau of Prisons' Use of Restrictive Housing for Inmates with Mental Illness 51 (2017); Office of the Inspector General, U.S. Dep't of Just., Review of the Federal Bureau of Prisons' Management of Its Female Inmate P

stice, Bureau of Prisons, Drug Abuse Treatment Program, 81 Fed. Reg. 24484, 24488 (Apr. 26, 2016) ("over 5,000 inmates waiting to enter treatment"); Colson Task Force, at 36 Cat the end of FY 2014, more than 12,300 people systemwide were awaiting drug abuse treatment'). 20 EFTA00094068 EXHIBIT B EFTA00094069